Download PDF
1 / Pages

Other users also viewed these articles

Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins; Sofia Pimenta; Daniela Oliveira; Rafaela Nicolau; Alexandra Bernardo; Teresa Martins Rocha; Lúcia Costa; Miguel Bernardes;
Reumatol Clin. 2024;20:380-5
Clinical impact of nailfold capillaroscopy in daily clinical practice Luis A. Torrens Cid; Christian Y. Soleto K; María Montoro-Álvarez; Claudia Sáenz Tenorio; Alicia Silva-Riveiro; Ana López-Cerón; Ana M. Anzola Alfaro; Liz Rocío Caballero Motta; Belén Serrano Benavente; Julia Martínez-Barrio; Juan G. Ovalles-Bonilla; Carlos M. González Fernández; Indalecio Monteagudo Sáez; Juan Carlos Nieto-González;
Reumatol Clin. 2021;17:258-62
Severe and life-threatening onset of systemic lupus erythematosus Ana Martins; Sofia Pimenta; Daniela Oliveira; Frederico Martins; Beatriz Samões; Lúcia Costa;
Reumatol Clin. 2023;19:402-3